Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ashish Sharma and Chiranjib Chakraborty.
Ashish Sharma
Connection Strength
5.966
Chiranjib Chakraborty
  1. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. mBio. 2021 08 31; 12(4):e0114021.
    View in: PubMed
    Score: 0.241
  2. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research. Int J Pept Res Ther. 2021; 27(4):2303-2311.
    View in: PubMed
    Score: 0.239
  3. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape. Front Immunol. 2021; 12:679344.
    View in: PubMed
    Score: 0.239
  4. SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection. Ann Med Surg (Lond). 2021 Jun; 66:102428.
    View in: PubMed
    Score: 0.237
  5. Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis. Vaccines (Basel). 2021 Jun 04; 9(6).
    View in: PubMed
    Score: 0.237
  6. Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2. Infect Genet Evol. 2021 09; 93:104951.
    View in: PubMed
    Score: 0.237
  7. All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently. Aging Dis. 2021 Jun; 12(3):688-690.
    View in: PubMed
    Score: 0.237
  8. The current second wave and COVID-19 vaccination status in India. Brain Behav Immun. 2021 Aug; 96:1-4.
    View in: PubMed
    Score: 0.237
  9. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2. Arch Med Res. 2021 05; 52(4):362-370.
    View in: PubMed
    Score: 0.232
  10. SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol. 2021 Feb; 14(2):225-238.
    View in: PubMed
    Score: 0.232
  11. SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics. Infect Genet Evol. 2021 04; 89:104729.
    View in: PubMed
    Score: 0.231
  12. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic. Immune Netw. 2021 Feb; 21(1):e5.
    View in: PubMed
    Score: 0.231
  13. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol. 2020 11; 85:104587.
    View in: PubMed
    Score: 0.227
  14. Response to: Status of Remdesivir: Not Yet Beyond Question! Arch Med Res. 2021 01; 52(1):104-106.
    View in: PubMed
    Score: 0.226
  15. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020; 11:1258.
    View in: PubMed
    Score: 0.225
  16. A SARS-CoV-2 vaccine candidate: In-silico cloning and validation. Inform Med Unlocked. 2020; 20:100394.
    View in: PubMed
    Score: 0.223
  17. COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol. 2020 11; 92(11):2260-2262.
    View in: PubMed
    Score: 0.222
  18. Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak. Arch Med Res. 2020 10; 51(7):728-730.
    View in: PubMed
    Score: 0.221
  19. Consider TLR5 for new therapeutic development against COVID-19. J Med Virol. 2020 11; 92(11):2314-2315.
    View in: PubMed
    Score: 0.221
  20. Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res. 2020 08; 51(6):595-597.
    View in: PubMed
    Score: 0.221
  21. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020 08; 51(6):585-586.
    View in: PubMed
    Score: 0.220
  22. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020 06; 92(6):618-631.
    View in: PubMed
    Score: 0.218
  23. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm. 2019 Mar 25; 559:360-372.
    View in: PubMed
    Score: 0.202
  24. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget. 2018 Feb 09; 9(11):10164-10174.
    View in: PubMed
    Score: 0.188
  25. miRNAs in Alzheimer Disease - A Therapeutic Perspective. Curr Alzheimer Res. 2017; 14(11):1198-1206.
    View in: PubMed
    Score: 0.175
  26. Micro-Environmental Signature of The Interactions between Druggable Target Protein, Dipeptidyl Peptidase-IV, and Anti-Diabetic Drugs. Cell J. 2017 Apr-Jun; 19(1):65-83.
    View in: PubMed
    Score: 0.174
  27. Regulatory functional territory of PLK-1 and their substrates beyond mitosis. Oncotarget. 2017 Jun 06; 8(23):37942-37962.
    View in: PubMed
    Score: 0.045
  28. Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis. Int J Mol Sci. 2017 Mar 12; 18(3).
    View in: PubMed
    Score: 0.044
  29. Suppression of osteogenic activity by regulation of WNT and BMP signaling during titanium particle induced osteolysis. J Biomed Mater Res A. 2017 03; 105(3):912-926.
    View in: PubMed
    Score: 0.044
  30. The crucial role and regulations of miRNAs in zebrafish development. Protoplasma. 2017 Jan; 254(1):17-31.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.